Cargando…
Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?
Although chemotherapy of tumours has scored successes, drug resistance remains the major cause of death of cancer patients. Initial treatment often leaves residual disease, from which the tumour regrows. Eventually, most tumours become resistant to all available chemotherapy. I call this pan-resista...
Autor principal: | Borst, Piet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376736/ https://www.ncbi.nlm.nih.gov/pubmed/22724067 http://dx.doi.org/10.1098/rsob.120066 |
Ejemplares similares
-
The metalloproteinase Papp-aa controls epithelial cell quiescence-proliferation transition
por: Liu, Chengdong, et al.
Publicado: (2020) -
Integration of pan-cancer transcriptomics with RPPA proteomics reveals mechanisms of epithelial-mesenchymal transition
por: Koplev, Simon, et al.
Publicado: (2018) -
EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures
por: Vasaikar, Suhas V., et al.
Publicado: (2020) -
Inhibiting the stringent response blocks Mycobacterium tuberculosis entry into quiescence and reduces persistence
por: Dutta, Noton K., et al.
Publicado: (2019) -
Monitoring Spontaneous Quiescence and Asynchronous Proliferation-Quiescence Decisions in Prostate Cancer Cells
por: Pulianmackal, Ajai J., et al.
Publicado: (2021)